Recent Quotes
My Watchlist
Indicators
Star 60
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

COMPASS Pathways Plc - American Depository Shares (NQ:CMPS)

11.34 +0.07 (+0.58%)
Delayed Quote Updated: 9:32 AM EDT, Oct 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about COMPASS Pathways Plc - American Depository Shares

< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
33 34 Next >
News headline image
Psychedelic Stock Gainers And Losers From April 10, 2023 ↗
 
Via Benzinga
News headline image
10 Short Squeeze Candidates: Getty Images Tops List, PaxMedica Rejoins Top Five, MicroStrategy Moves Up And More ↗
Potential short squeeze plays gained steam in 2021 and continued through 2023 with new traders looking for the next huge move. High short interest and high cost to borrow are among the common traits... 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From April 7, 2023 ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From April 6, 2023 ↗
 
Via Benzinga
News headline image
Compass Pathways, GH Research Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From April 4, 2023 ↗
 
Via Benzinga
Compass Pathways Plc (NASDAQ: CMPS) Highlighted for Surprising Price Action
Via Investor Brand Network
News headline image
Seelos Therapeutics, ATAI Life Sciences Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
What To Expect From The Benzinga Psychedelics Capital Conference, The Must-Attend Event For This Emerging Industry ↗
The world of psychedelics is evolving rapidly, and the Benzinga Psychedelics Capital Conference is the premier event for those who want to be part of this exciting journey. 
Via Benzinga
News headline image
5 Short Squeeze Stocks To Watch: Unicycle Therapeutics, Getty Images And More ↗
Potential short squeeze plays gained steam in 2021 and continued through 2022 with new traders looking for the next huge move. High short interest and high cost to borrow are among the common traits... 
Via Benzinga
News headline image
Largest Psychedelic Stocks -3.4% In March ↗
The munKNEE Psychedelic Drug Stocks Index was down 3.4% in March but is still +1.2% YTD. The best news is the continuing high price targets being set by analysts. 
Via Talk Markets
News headline image
Psychedelic Stock Gainers And Losers From March 31, 2023 ↗
 
Via Benzinga
News headline image
Seelos Therapeutics, Mind Medicine Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From March 29, 2023 ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From March 28, 2023 ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From March 27, 2023 ↗
 
Via Benzinga
News headline image
10 Short Squeeze Candidates: Unicycle Therapeutics, Compass Pathways, Virgin Orbit Among Those To Watch ↗
Potential short squeeze plays gained steam in 2021 and continued through 2022 with new traders looking for the next huge move. High short interest and a high cost to borrow are among the common traits... 
Via Benzinga
News headline image
Cannabis Category Performances Ranged From +8.6% To -7.0% This Week ↗
The 5 categories in the cannabis sector perform quite differently from each other and this week was a prime example. 
Via Talk Markets
News headline image
GH Research, Cybin Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Atai Life Sciences Hopes Hercules Can Help 'Sustain' Operations Until 2026 ↗
Biopharma company Atai Life Sciences' (NASDAQ: ATAI) fourth quarter and full year 2022 consolidated financial results show: 
Via Benzinga
News headline image
GH Research, Compass Pathways Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From March 22, 2023 ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From March 21, 2023 ↗
 
Via Benzinga
News headline image
EXCLUSIVE: NYC Ketamine Center Co-Founder On Prices, Insurance, Competition & Expansion ↗
This is the third article of a three-part series, you can find the first and 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From March 20, 2023 ↗
 
Via Benzinga
News headline image
Psyched: 22 States With Reform Bills, Ketamine Therapy Services Today, Oscars On Shrooms & More ↗
Psychedelics Reform Update: 22 States Where Proposals Are Being Discussed & Local Moves Considered 
Via Benzinga
News headline image
The "Rags-To-Riches" Portfolio: An Update ↗
Cannabis, psychedelic, and plant-based food stocks performed extremely poorly in 2022, down 73% vs. 2021 but perhaps some of them will bounce back with major returns in 2023. 
Via Talk Markets
News headline image
Psychedelic Stock Gainers And Losers From March 17, 2023 ↗
 
Via Benzinga
News headline image
Seelos Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Seelos Therapeutics, Cybin Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
33 34 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.